AKT1 and non-small cell lung carcinoma: ✓ miR-497 overexpression can reverse drug resistance of NSCLC cells to EGFR-TKI by inhibiting the expression of IGF1R protein and blocking the activation of its downstream AKT1 signaling pathway.